Free Trial

SNDL (SNDL) Competitors

SNDL logo
$1.42 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.42 0.00 (-0.35%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNDL vs. ACB, CGC, CRON, OGI, TLRY, TVTX, CVAC, PAHC, ABCL, and CALT

Should you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), Travere Therapeutics (TVTX), CureVac (CVAC), Phibro Animal Health (PAHC), AbCellera Biologics (ABCL), and Calliditas Therapeutics AB (publ) (CALT). These companies are all part of the "pharmaceutical products" industry.

SNDL vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

47.6% of Aurora Cannabis shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Aurora Cannabis has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, SNDL has a beta of 3.4, indicating that its stock price is 240% more volatile than the S&P 500.

SNDL has a consensus price target of $3.63, suggesting a potential upside of 155.28%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
3.67
SNDL
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, SNDL had 2 more articles in the media than Aurora Cannabis. MarketBeat recorded 5 mentions for SNDL and 3 mentions for Aurora Cannabis. SNDL's average media sentiment score of 0.53 beat Aurora Cannabis' score of 0.33 indicating that SNDL is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
SNDL
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aurora Cannabis has a net margin of 1.32% compared to SNDL's net margin of -11.48%. Aurora Cannabis' return on equity of 0.13% beat SNDL's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis1.32% 0.13% 0.10%
SNDL -11.48%-9.02%-7.60%

Aurora Cannabis has higher earnings, but lower revenue than SNDL. SNDL is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$246.72M1.07$1.63M$0.1142.64
SNDL$671.81M0.56-$69.18M-$0.29-4.90

Summary

Aurora Cannabis beats SNDL on 11 of the 16 factors compared between the two stocks.

Get SNDL News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDL vs. The Competition

MetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$373.14M$10.57B$5.56B$9.04B
Dividend YieldN/A2.08%5.25%4.03%
P/E Ratio-4.9016.5627.1820.14
Price / Sales0.5630.26440.78137.14
Price / CashN/A22.8437.5058.41
Price / Book0.453.758.085.60
Net Income-$69.18M$235.43M$3.16B$248.43M
7 Day Performance11.37%3.78%3.77%5.15%
1 Month Performance7.58%3.95%3.90%7.62%
1 Year Performance-30.39%-9.49%34.22%21.56%

SNDL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNDL
SNDL
3.6638 of 5 stars
$1.42
flat
$3.63
+155.3%
-27.9%$373.14M$671.81M-4.902,516News Coverage
Gap Down
ACB
Aurora Cannabis
0.3488 of 5 stars
$4.43
-2.4%
N/A-14.6%$249.01M$246.72M40.271,130
CGC
Canopy Growth
0.8042 of 5 stars
$1.20
-6.3%
$2.00
+66.7%
-79.6%$220.64M$225.65M-0.303,150News Coverage
CRON
Cronos Group
2.2936 of 5 stars
$2.04
flat
N/A-7.1%$786.79M$117.61M15.69450News Coverage
OGI
Organigram Global
0.9872 of 5 stars
$1.39
-2.8%
N/A-8.3%$186.18M$117.47M13.90860News Coverage
TLRY
Tilray Brands
2.2037 of 5 stars
$0.50
-6.6%
$1.92
+280.7%
-61.6%$506.67M$788.94M-0.482,650News Coverage
TVTX
Travere Therapeutics
3.2115 of 5 stars
$14.60
-2.7%
$32.14
+120.2%
+72.1%$1.30B$273.53M-5.20460
CVAC
CureVac
4.7316 of 5 stars
$5.41
-0.7%
$6.83
+26.3%
+79.7%$1.21B$523.70M5.88880
PAHC
Phibro Animal Health
3.7136 of 5 stars
$29.90
+6.8%
$24.40
-18.4%
+83.1%$1.21B$1.02B38.331,940Analyst Upgrade
High Trading Volume
ABCL
AbCellera Biologics
2.5685 of 5 stars
$4.03
+6.1%
$7.50
+86.1%
+49.6%$1.20B$28.83M-7.20500News Coverage
Analyst Forecast
Analyst Revision
High Trading Volume
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
N/AN/A$1.19B$1.60B-21.62180

Related Companies and Tools


This page (NASDAQ:SNDL) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners